✦ LIBER ✦

A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma

✍ Scribed by Alberto S. Pappo; Erlinda Etcubanas; Victor M. Santana; Bhaskar N. Rao; Larry E. Kun; James Fontanesi; Paula K. Roberson; Laura C. Bowman; William M. Crist; David N. Shapiro

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 680 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930315)71:6<2119::aid-cncr2820710629>3.0.co;2-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Upfront window trial of topotecan in pre

Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma : Children's Cancer Group (CCG) 7943

✍ Nita L. Seibel; Mark Krailo; Zhengjia Chen; John Healey; Philip P. Breitfeld; Ri 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

## Abstract ## BACKGROUND. Patients with metastatic osteosarcoma have a poor prognosis. The objectives of the study were to determine the antitumor activity and toxicity of topotecan (daily ×5) in newly diagnosed patients with metastatic osteosarcoma followed by chemotherapy (ifosfamide, carboplat

A phase II study of the combination of c

A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma

✍ T. Le Chevalier; F. Thomas; R. Subirana; P. Baldeyrou; P. Ruffie; T. Tursz; R. A 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB 👁 2 views

Efficacy of ifosfamide and doxorubicin g

Efficacy of ifosfamide and doxorubicin given as a phase II ?window? in children with newly diagnosed metastatic rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group

✍ Sandler, E. ;Lyden, E. ;Ruymann, F. ;Maurer, H. ;Wharam, M. ;Parham, D. ;Link, M 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract ## Background The cure rate for children/adolescents with localized rhabdomyosarcoma (RMS) has tripled over the past 25 years, but patients with metastatic disease at presentation have not benefited similarly, and urgently need new therapy. We evaluated a new drug pair, ifosfamide + do

Induction paclitaxel in previously untre

Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck : A Phase II trial

✍ John C. Grecula; Roy E. Smith; Chris A. Rhoades; Pramod Sharma; Amit Agrawal; Ho 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 3 views

A Phase II trial of 5-fluorouracil and r

A Phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma

✍ Richard Pazdur; Jaffer A. Ajani; Rodger Winn; James Bearden; Robert J. Belt; Sus 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 3 views

A Phase I1 clinical trial of the combination of 5-fluorouracil (5-FU) and recombinant alpha-2a-interferon (a-2a-IFN) was conducted in 44 patients. Patients had not received chemotherapy previously and had measurable metastatic gastric carcinoma. 5-FU was administered as a continuous infusion at a do

Phase II study of daunorubicin in previo

Phase II study of daunorubicin in previously untreated patients with advanced colorectal carcinoma

✍ Harvey, J. ;Bonnem, E. ;Grady, K. ;Goodman, A. ;Schein, P. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Fourteen patients with advanced measurable colorectal cancer were treated with daunorubicin hydrochloride (DNR). The drug was administered at a dose of 15 mg/m2 on day 1 through 3 and 8 through 10. After a Cday rest period DNR was given in weekly injections of 15 mg/m2. There were no partial or comp